收费全文 | 16260篇 |
免费 | 943篇 |
国内免费 | 152篇 |
耳鼻咽喉 | 180篇 |
儿科学 | 360篇 |
妇产科学 | 233篇 |
基础医学 | 1848篇 |
口腔科学 | 393篇 |
临床医学 | 1434篇 |
内科学 | 5094篇 |
皮肤病学 | 188篇 |
神经病学 | 1599篇 |
特种医学 | 629篇 |
外科学 | 2401篇 |
综合类 | 34篇 |
一般理论 | 1篇 |
预防医学 | 529篇 |
眼科学 | 133篇 |
药学 | 726篇 |
中国医学 | 10篇 |
肿瘤学 | 1563篇 |
2023年 | 136篇 |
2022年 | 227篇 |
2021年 | 431篇 |
2020年 | 298篇 |
2019年 | 381篇 |
2018年 | 438篇 |
2017年 | 348篇 |
2016年 | 430篇 |
2015年 | 449篇 |
2014年 | 641篇 |
2013年 | 852篇 |
2012年 | 1215篇 |
2011年 | 1282篇 |
2010年 | 711篇 |
2009年 | 722篇 |
2008年 | 1126篇 |
2007年 | 1173篇 |
2006年 | 1070篇 |
2005年 | 1063篇 |
2004年 | 1045篇 |
2003年 | 861篇 |
2002年 | 778篇 |
2001年 | 135篇 |
2000年 | 101篇 |
1999年 | 142篇 |
1998年 | 135篇 |
1997年 | 133篇 |
1996年 | 100篇 |
1995年 | 89篇 |
1994年 | 67篇 |
1993年 | 79篇 |
1992年 | 71篇 |
1991年 | 78篇 |
1990年 | 52篇 |
1989年 | 45篇 |
1988年 | 39篇 |
1987年 | 38篇 |
1986年 | 64篇 |
1985年 | 38篇 |
1984年 | 47篇 |
1983年 | 31篇 |
1982年 | 22篇 |
1981年 | 18篇 |
1980年 | 17篇 |
1978年 | 13篇 |
1977年 | 10篇 |
1976年 | 14篇 |
1972年 | 11篇 |
1968年 | 12篇 |
1967年 | 12篇 |
Area covered: The current review is provided to update recent developments in the clinical application of cyclin/CDK inhibitors to breast cancer with a focus on the anti-tumor immune response.
Expert opinion: The cyclin D1 gene encodes the regulatory subunit of a proline-directed serine-threonine kinase that phosphorylates several substrates. CDKs possess phosphorylation site selectivity, with the phosphate-acceptor residue preceding a proline. Several important proteins are substrates including all three retinoblastoma proteins, NRF1, GCN5, and FOXM1. Over 280 cyclin D3/CDK6 substrates have b\een identified. Given the diversity of substrates for cyclin/CDKs, and the altered thresholds for substrate phosphorylation that occurs during the cell cycle, it is exciting that small molecular inhibitors targeting cyclin D/CDK activity have encouraging results in specific tumors. 相似文献
Background
Limited data exists demonstrating the efficacy of minimally invasive surgery (MIS) compared to median sternotomy (MS) for multiple valvular disease (MVD). This systematic review and meta-analysis aims to compare operative and peri-operative outcomes of MIS vs MS in MVD.Methods
PubMed, Ovid, and Embase were searched from inception until August 2019 for randomized and observational studies comparing MIS and MS in patients with MVD. Clinical outcomes of intra- and postoperative times, reoperation for bleeding and surgical site infection were evaluated.Results
Five observational studies comparing 340 MIS vs 414 MS patients were eligible for qualitative and quantitative review. The quality of evidence assessed using the Newcastle-Ottawa scale was good for all included studies. Meta-analysis demonstrated increased cardiopulmonary bypass time for MIS patients (weighted mean difference [WMD], 0.487; 95% confidence interval [CI], 0.365-0.608; P < .0001). Similarly, aortic cross-clamp time was longer in patients undergoing MIS (WMD, 0.632; 95% CI, 0.509-0.755; P < .0001). No differences were found in operative mortality, reoperation for bleeding, surgical site infection, or hospital stay.Conclusions
MIS for MVD have similar short-term outcomes compared to MS. This adds value to the use of minimally invasive methods for multivalvular surgery, despite conferring longer operative times. However, the paucity in literature and learning curve associated with MIS warrants further evidence, ideally randomized control trials, to support these findings.Methods: A total of 32 HIV+ patients, 11 with uveitis/retinitis before surgery and 21 without, mean follow-up 44.9 ± 36.6 months, and 114 HIV- patients, 57 with uveitis/retinitis before surgery and 57 without, were retrospectively compared.
Results: Visual acuity improved in all HIV+ patients (p < 0.001), who were younger (p = 0.01) and more frequently males (p = 0.027). HIV+ patients with uveitis prior surgery improved less (p = 0.046) than HIV- (p < 0.001); their anterior chamber inflammation was similar to baseline. Male sex (p = 0.005), younger age (p < 0.001), dyslipidaemia (p = 0.058), HBV+ (p = 0.037), and unilateral cataract (p = 0.001) were more frequent in HIV+ patients with senile cataract, but they showed the same postoperative course as HIV- patients.
Conclusion: Cataract surgery in HIV+ patients is safe and effective. Uveitis prior to surgery did not significantly affect the postoperative course. Systemic comorbidities are more frequent in HIV+ patients with senile cataract than in HIV- subjects. 相似文献